A case of lung cancer associated with pneumoconiosis diagnosed by fluorine-18 fluorodeoxyglucose positron emission tomography

Shuji Bandoh; Jiro Fujita; Yuka Yamamoto; Yoshihiro Nishiyama; Yutaka Ueda; Yasunori Tojo; Tomoya Ishii; Akihito Kubo; Toshihiko Ishida

doi:10.1007/BF03006674

A case of lung cancer associated with pneumoconiosis diagnosed by fluorine-18 fluorodeoxyglucose positron emission tomography

Ann Nucl Med. 2003 Oct;17(7):597-600. doi: 10.1007/BF03006674.

Authors

Shuji Bandoh¹, Jiro Fujita, Yuka Yamamoto, Yoshihiro Nishiyama, Yutaka Ueda, Yasunori Tojo, Tomoya Ishii, Akihito Kubo, Toshihiko Ishida

Affiliation

¹ First Department of Internal Medicine, Kagawa Medical University, Kita-gun, Japan. [email protected]

PMID: 14651360
DOI: 10.1007/BF03006674

Abstract

We report a case of lung cancer arising from progressive massive fibrosis (PMF) associated with pneumoconiosis. In this case, fluorine-18 fluorodeoxyglucose positron emission tomography (FDG-PET) was able to clearly distinguish the lung cancer from PMF, suggesting a potential usefulness of FDG-PET in cancer screening in patients with pneumoconiosis. To our knowledge, this is the first description of an FDG-PET image of lung cancer arising from PMF.

Publication types

Case Reports
Comparative Study

MeSH terms

Fluorodeoxyglucose F18*
Humans
Lung Neoplasms / diagnosis
Lung Neoplasms / diagnostic imaging
Lung Neoplasms / etiology
Male
Middle Aged
Pneumoconiosis / complications*
Pneumoconiosis / diagnosis
Pneumoconiosis / diagnostic imaging*
Pulmonary Fibrosis / diagnosis
Pulmonary Fibrosis / diagnostic imaging*
Pulmonary Fibrosis / etiology*
Radiopharmaceuticals
Solitary Pulmonary Nodule / diagnosis
Solitary Pulmonary Nodule / diagnostic imaging*
Solitary Pulmonary Nodule / etiology*
Tomography, Emission-Computed / methods*

Substances

Radiopharmaceuticals
Fluorodeoxyglucose F18